Buy Tb-500 peptide online – at Peptira

TB-500 Peptide Research

Buy Tb-500 peptide is a synthetic peptide commonly identified as the N-terminally acetylated 17–23 fragment of human thymosin beta-4 (Ac-LKKTETQ). Thymosin beta-4 is a naturally occurring 43-amino-acid peptide associated with actin biology and cellular processes. This has been investigated as a shorter peptide sequence representing an active region of thymosin beta-4.

Research Material for Laboratory Applications

Buy Tb-500 peptide is intended for qualified laboratory and analytical research involving peptide biology, cellular signaling, cytoskeletal processes, and molecular interactions. Researchers can study the peptide in controlled experimental systems to examine its structural characteristics and biological activity.

The identity of this is documented by the FDA as the N-terminal acetylated 17–23 fragment of thymosin beta-4, with the sequence N-acetyl-Leu-Lys-Lys-Thr-Glu-Thr-Gln.

Actin and Cellular Research

Thymosin beta-4 is known for its relationship with actin, an important structural protein involved in cell shape, movement, and organization. Research into thymosin beta-4-derived sequences has therefore examined how shorter peptide fragments interact with actin-related cellular processes.

Experimental studies have investigated the LKKTETQ region in relation to actin binding, cell migration, and angiogenesis-related biological processes. These findings provide a basis for continued laboratory investigation into peptide-mediated cellular mechanisms.

Cell Migration and Angiogenesis Research

TB-500 has been studied in experimental models involving cell migration and vascular biology. Research on thymosin beta-4-derived peptides has examined processes such as endothelial-cell activity, angiogenesis, and tissue-associated cellular responses. These findings are primarily from preclinical research and should not be interpreted as evidence of established human therapeutic effects.

Researchers may use TB-500 as a model peptide when investigating relationships between short peptide sequences, cytoskeletal organization, cellular movement, and signaling pathways.

Research and Regulatory Context

This should be clearly distinguished from full-length thymosin beta-4. Although the two are structurally related, TB-500 is a shorter peptide fragment rather than the complete 43-amino-acid thymosin beta-4 molecule. Analytical research has specifically identified TB-500 as the acetylated LKKTETQ sequence.

FDA materials currently indicate limited human safety information for TB-500-related substances and note potential concerns involving immunogenicity, aggregation, and peptide-related impurities.

Laboratory Research Use Only

This is offered strictly as research material for qualified scientific and analytical applications. It is not marketed as a medication, dietary supplement, or treatment and is not intended for human or veterinary use.

Researchers should handle, store, and analyze TB-500 according to appropriate institutional laboratory procedures, applicable safety requirements, and validated research protocols.

Important Research Notice

The information presented describes areas investigated in published TB-500 and thymosin beta-4 research. It should not be interpreted as a claim that this diagnoses, treats, prevents, or cures any disease or medical condition. Experimental findings may vary according to the research model, concentration, formulation, analytical method, and study conditions.